ziprasidone hydrochloride
- RxCUI
- 1294533
- RxNorm name
- ziprasidone hydrochloride
- Term type
- PIN
- Status
- Active
- Updated
- 2026-10-04 01:57:59
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 062012
- Active start
- 062012
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| ziprasidone | 115698 |
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ziprasidone hydrochloride | ZIPRASIDONE HYDROCHLORIDE | Bryant Ranch Prepack | 5d576819-cd14-4a61-8a2f-6b90d8eac07e | 2026-07-16 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | REMEDYREPACK INC. | c9f8f635-cf3f-4c42-8bd1-45bbe19bf97e | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | REMEDYREPACK INC. | a66a0b25-673c-4a3d-b923-5f65a02b8ff0 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | REMEDYREPACK INC. | 4e7e2d5d-8ea8-4c25-a500-f4794542fda2 | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| ziprasidone hydrochloride | ZIPRASIDONE HYDROCHLORIDE | REMEDYREPACK INC. | 56370be6-42a2-4962-acdc-22b7c6e0e7fe | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| ziprasidone hydrochloride | ZIPRASIDONE HYDROCHLORIDE | Bryant Ranch Prepack | 14191e0d-8219-4f6e-b808-09c4804a8262 | 2026-03-12 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | Bryant Ranch Prepack | 7c683604-b827-434d-aff3-ee2ed0565cd7 | 2026-03-11 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | Aurobindo Pharma Limited | cc5e1c44-79e9-45d3-b1e5-b003f550c508 | 2025-05-09 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | BluePoint Laboratories | c0eb7b4d-0264-4eed-8756-51bba3af82fb | 2025-04-15 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| ziprasidone hydrochloride | ZIPRASIDONE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | fc9ffbc3-1f16-9265-e053-6294a90acfd2 | 2025-02-05 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | A-S Medication Solutions | c3797145-cead-4fc4-9711-8b8623bb09f4 | 2024-11-13 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | Bryant Ranch Prepack | 550aca3a-5051-432e-9a3f-a2e53cbd603d | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 0fcebd61-25b2-d287-e063-6394a90a7b9a | 2024-01-25 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | Bryant Ranch Prepack | 798631b6-b9d9-44de-9a1a-ae2cee86d531 | 2023-11-20 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | Bryant Ranch Prepack | fa70291d-8455-40d6-9b73-bf91880f9979 | 2023-10-25 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| ziprasidone hydrochloride | ZIPRASIDONE HYDROCHLORIDE | Bryant Ranch Prepack | 48e6e141-66d3-4eab-b0bf-dfd1d44b4832 | 2023-09-07 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
| Ziprasidone Hydrochloride | ZIPRASIDONE HYDROCHLORIDE | Macleods Pharmaceuticals Limited | 3e0d1436-2e2b-4c34-a9bc-4a6b2ac38af0 | 2023-02-24 | Boxed warning, Warnings, Adverse reactions | ZIPRASIDONE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N05AE | Indole derivatives | ATC1-4 | ziprasidone | |
| FDASPL | N0000175430 | Atypical Antipsychotic | EPC | has_epc | ziprasidone |
| MEDRT | D010879 | Piperazines | CHEM | has_ingredient | ziprasidone hydrochloride |
| MEDRT | D010879 | Piperazines | CHEM | has_ingredient | ziprasidone |
| MEDRT | D013844 | Thiazoles | CHEM | has_ingredient | ziprasidone |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | ziprasidone |
| MEDRT | D001145 | Arrhythmias, Cardiac | DISEASE | ci_with | ziprasidone hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ziprasidone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ziprasidone hydrochloride |
| MEDRT | D006333 | Heart Failure | DISEASE | ci_with | ziprasidone |
| MEDRT | D006333 | Heart Failure | DISEASE | ci_with | ziprasidone hydrochloride |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | ziprasidone |
| MEDRT | D009203 | Myocardial Infarction | DISEASE | ci_with | ziprasidone hydrochloride |
| MEDRT | D012559 | Schizophrenia | DISEASE | may_treat | ziprasidone hydrochloride |
| MEDRT | D012559 | Schizophrenia | DISEASE | may_treat | ziprasidone |
| MEDRT | D005879 | Tourette Syndrome | DISEASE | may_treat | ziprasidone |
| MEDRT | D005879 | Tourette Syndrome | DISEASE | may_treat | ziprasidone hydrochloride |
| MEDRT | N0000000099 | Adrenergic alpha-Antagonists | MOA | has_moa | ziprasidone hydrochloride |
| MEDRT | N0000000099 | Adrenergic alpha-Antagonists | MOA | has_moa | ziprasidone |
| MEDRT | N0000000230 | Dopamine Antagonists | MOA | has_moa | ziprasidone hydrochloride |
| MEDRT | N0000000230 | Dopamine Antagonists | MOA | has_moa | ziprasidone |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | ziprasidone |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | ziprasidone hydrochloride |
| MEDRT | N0000000130 | Serotonin Antagonists | MOA | has_moa | ziprasidone hydrochloride |
| MEDRT | N0000000130 | Serotonin Antagonists | MOA | has_moa | ziprasidone |
| MEDRT | N0000008588 | Decreased Dopamine Activity | PE | has_pe | ziprasidone |
| MEDRT | N0000008588 | Decreased Dopamine Activity | PE | has_pe | ziprasidone hydrochloride |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | ziprasidone |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | ziprasidone hydrochloride |
| MEDRT | N0000008764 | Decreased Norepinephrine Activity | PE | has_pe | ziprasidone |
| MEDRT | N0000008764 | Decreased Norepinephrine Activity | PE | has_pe | ziprasidone hydrochloride |
| MEDRT | N0000008893 | Decreased Serotonin Activity | PE | has_pe | ziprasidone |
| MEDRT | N0000008893 | Decreased Serotonin Activity | PE | has_pe | ziprasidone hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| CODES | SNOMEDCT | 129479007 |
| CODES | USP | m89915 |
| CODES | VUID | 4030214 |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |